Pharmacokinetic drug-drug interaction between olaparib and apixaban: a case report

Cancer Chemother Pharmacol. 2024 May;93(5):519-521. doi: 10.1007/s00280-023-04606-8. Epub 2023 Nov 3.

M Berge^#¹, J S Giraud^#², S De Percin³, A Puszkiel^{4

5}, A Thomas-Schoemann^{2

6}, B Blanchet^{4

6}

¹ Department of Clinical Pharmacy, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, CARPEM, 75014, Paris, France. marion.berge@aphp.fr.
² Department of Clinical Pharmacy, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, CARPEM, 75014, Paris, France.
³ Department of Medical Oncology, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, CARPEM, 75014, Paris, France.
⁴ Department of Pharmacokinetics and Pharmacochemistry, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris, CARPEM, 75014, Paris, France.
⁵ Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, Inserm UMRS-1144, 75006, Paris, France.
⁶ Faculté de Pharmacie, Université Paris Cité, UMR8038 CNRS, U1268 INSERM, PRES Sorbonne Paris Cité, CARPEM, Paris, France.

^# Contributed equally.

No abstract available

Publication types